Skip to main content

Table 1 Comparison of patient characteristics

From: Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice

 

SMI/AP-only group

n = 1383

SMI/AP + DM group

n = 206

SMI/AP + CVD group

n = 116

Total sample

n = 1705

Sex female

720 (52.1)

110 (53.4)

51 (44.0)

881 (51.7)

Mean age in years (SD)

44.9 (14.8)

58.5 (14.0)

61.8 (12.3)

47.7 (15.7)

SMI diagnosis, total

629 (45.5)

97 (47.1)

48 (41.4)

834 (48.9)

 Schizophrenia

197 (14.2)

38 (18.4)

15 (12.9)

250 (14.7)

 Affective Psychosis/Bipolar Disorder

217 (15.7)

34 (16.5)

24 (20.7)

275 (16.1)

 Psychosis Not Otherwise Specified

307 (22.2)

28 (13.6)

11 (9.5)

346 (20.3)

SMI/AP

 SMI with AP

290 (21.0)

55 (26.7)

20 (17.2)

365 (21.4)

 SMI without AP

399 (28.9)

42 (20.4)

28 (24.1)

469 (27.5)

 AP without SMI

630 (45.6)

95 (46.1)

60 (51.7)

785 (46.0)

 Only lithium

64 (4.6)

14 (6.8)

8 (6.9)

86 (5.1)

Medication use

 Antipsychotics, total

920 (66.5)

150 (72.8)

80 (69.0)

1150 (67.4)

 Lithium

160 (11.6)

31 (15.0)

22 (19.0)

213 (12.5)

 Antidepressants

558 (40.3)

91 (44.2)

58 (50)

707 (41.5)

 CVR lowering medication

295 (21.3)

186 (90.3)

103 (88.8)

584 (34.3)

Comorbidity

 COPD

65 (4.7)

25 (12.1)

23 (19.8)

113 (6.6)

 Alcohol abuse

68 (4.9)

19 (9.2)

12 (10.3)

99 (5.8)

 Tobacco abuse

233 (16.8)

83 (40.3)

42 (36.2)

358 (21.0)

 Drug abuse

101 (7.3)

3 (1.5)

2 (1.7)

106 (6.2)

Number of visits FP /year

 0

393 (28.4)

46 (22.3)

25 (21.6)

464 (27.2)

 1–5

565 (40.9)

60 (29.1)

27 (23.3)

652 (38.2)

 6–10

234 (16.9)

41 (19.9)

27 (23.3)

302 (17.7)

  > 10

191 (13.8)

59 (28.6)

37 (31.09)

287 (16.8)

  1. Values are shown as n (%) unless otherwise noted
  2. SMI Serious Mental Illness, AP Antipsychotics, DM Diabetes Mellitus, CVD Cardiovascular Disease, CVR Cardiovascular Risk, FP Family practice, COPD chronic obstructive pulmonary disease